Jennifer Michaelson - Jul 1, 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Chief Scientific Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Jul 1, 2024
Transactions value $
$21,240
Form type
4
Date filed
7/2/2024, 07:30 PM
Previous filing
May 8, 2024
Next filing
Jul 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Award $21.2K +2.36K +1.82% $9.00* 132K Jul 1, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2024 through June 30, 2024. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 2, 2024.